help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maniotis, A. J.
Right arrow Articles by Folberg, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maniotis, A. J.
Right arrow Articles by Folberg, R.
(American Journal of Pathology. 2005;166:1187-1203.)
© 2005 American Society for Investigative Pathology

Chromatin Organization Measured by AluI Restriction Enzyme Changes with Malignancy and Is Regulated by the Extracellular Matrix and the Cytoskeleton

Andrew J. Maniotis*{dagger}, Klara Valyi-Nagy*{dagger}, John Karavitis*, Jonas Moses*, Viveka Boddipali*, Ying Wang*, Rafael Nuñez*{dagger}, Suman Setty*, Zarema Arbieva{ddagger}, Mina J. Bissell§ and Robert Folberg*{dagger}

From the Department of Pathology,* the Cancer Center,{dagger} and the Core Genomics Facility,{ddagger} the University of Illinois at Chicago, Chicago, Illinois; and the Life Sciences Division,§ Lawrence Berkeley National Laboratory, Berkeley, California

Given that expression of many genes changes when cells become malignant or are placed in different microenvironments, we asked whether these changes were accompanied by global reorganization of chromatin. We reasoned that sequestration or exposure of chromatin-sensitive sites to restriction enzymes could be used to detect this reorganization. We found that AluI-sensitive sites of nonmalignant cells were relatively more exposed compared to their malignant counterparts in cultured cells and human tumor samples. Changes in exposure and sequestration of AluI-sensitive sites in normal fibroblasts versus fibrosarcoma or those transfected with oncogenes, nonmalignant breast cells versus carcinomas and poorly metastatic versus highly invasive melanoma were shown to be independent of the cell cycle and may be influenced by proteins rich in disulfide bonds. Remarkably, regardless of degree of malignancy, AluI-sensitive sites became profoundly sequestered when cells were incubated with laminin, Matrigel, or a circular RGD peptide (RGD-C), but became exposed when cells were placed on collagen I or in serum-containing medium. Disruption of the actin cytoskeleton led to exposure, whereas disruption of microtubules or intermediate filaments exerted a sequestering effect. Thus, AluI-sensitive sites are more sequestered with increasing malignant behavior, but the sequestration and exposure of these sites is exquisitely sensitive to information conferred to the cell by molecules and biomechanical forces that regulate cellular and tissue architecture.




This article has been cited by other articles:


Home page
 IOVSHome page
R. Folberg, S. S. Kadkol, S. Frenkel, K. Valyi-Nagy, M. J. Jager, J. Pe'er, and A. J. Maniotis
Authenticating Cell Lines in Ophthalmic Research Laboratories
Invest. Ophthalmol. Vis. Sci., November 1, 2008; 49(11): 4697 - 4701.
[Full Text] [PDF]

Home page
 IOVSHome page
V. Barak, S. Frenkel, K. Valyi-Nagy, L. Leach, M. A. Apushkin, A. Y. Lin, I. Kalickman, N. A. Baumann, J. Pe'er, A. J. Maniotis, et al.
Using the Direct-Injection Model of Early Uveal Melanoma Hepatic Metastasis to Identify TPS as a Potentially Useful Serum Biomarker
Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4399 - 4402.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
R. Folberg, L. Leach, K. Valyi-Nagy, A. Y. Lin, M. A. Apushkin, Z. Ai, V. Barak, D. Majumdar, J. Pe'er, and A. J. Maniotis
Modeling the Behavior of Uveal Melanoma in the Liver
Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 2967 - 2974.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
T. Sandal, K. Valyi-Nagy, V. A. Spencer, R. Folberg, M. J. Bissell, and A. J. Maniotis
Epigenetic Reversion of Breast Carcinoma Phenotype Is Accompanied by Changes in DNA Sequestration as Measured by AluI Restriction Enzyme
Am. J. Pathol., May 1, 2007; 170(5): 1739 - 1749.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Rieber, M. Strasberg-Rieber, A. J. Maniotis, and R. Folberg
Different Chromatin Organization in Benign and Malignant Cells Revealed by Unequal Nuclease Sensitivity between Tumor and Normal Cell Genomes
Am. J. Pathol., February 1, 2007; 170(2): 787 - 789.
[Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
R. Folberg, Z. Arbieva, J. Moses, A. Hayee, T. Sandal, S. Kadkol, A. Y. Lin, K. Valyi-Nagy, S. Setty, L. Leach, et al.
Tumor Cell Plasticity in Uveal Melanoma: Microenvironment Directed Dampening of the Invasive and Metastatic Genotype and Phenotype Accompanies the Generation of Vasculogenic Mimicry Patterns
Am. J. Pathol., October 1, 2006; 169(4): 1376 - 1389.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S. S. Kadkol, A. Y. Lin, V. Barak, I. Kalickman, L. Leach, K. Valyi-Nagy, D. Majumdar, S. Setty, A. J. Maniotis, R. Folberg, et al.
Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study.
Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 802 - 806.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
G. S. Stein
Mechanogenomic Control of DNA Exposure and Sequestration
Am. J. Pathol., April 1, 2005; 166(4): 959 - 962.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Society for Investigative Pathology.